Characterization of purified human recombinant cytochrome P4501A1- Ile462 and -Val462: Assessment of a role for the rare allele in carcinogenesis

Cancer Research

Volumn 56, Issue 17, 1996, Pages 3926-3933

  Zhang, Zhi Yi ^a   Fasco, Michael J ^a,b   Huang, Lili ^a   Guengerich, F Peter ^c   Kaminsky, Laurence S ^a,b,d  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; CYTOCHROME P450 ISOENZYME; EPOXIDE HYDROLASE; ETHOXYRESORUFIN; ISOLEUCINE; VALINE; WARFARIN;

ALPHA HELIX; ARTICLE; CIRCULAR DICHROISM; ESCHERICHIA COLI; LUNG CANCER; LUNG CARCINOGENESIS; MICHAELIS CONSTANT; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; SITE DIRECTED MUTAGENESIS; STEREOCHEMISTRY;

ALLELES; BASE SEQUENCE; CYTOCHROME P-450 ENZYME SYSTEM; DNA, COMPLEMENTARY; ESCHERICHIA COLI; HUMANS; ISOENZYMES; ISOLEUCINE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NEOPLASMS; PLASMIDS; RECOMBINANT PROTEINS; VALINE; WARFARIN;

EID: 0029841793     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Shimada, T., Yun, C-H , Yamazaki, H , Gautier, J-C., Beaune, P. H., and Guengerich, F. P. Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens Mol Pharmacol., 41 856-864, 1992
2. McManus, M E , Burgess, W. M , Veronese, M. E , Huggett, A , Quattrochi, L C and Tukey, R H. Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450 Cancer Res , 50: 3367-3376, 1990
3. Bauer, E., Guo, Z , Ueng, Y-F , Bell, L. C., Zeldin, D., and Guengerich, F. P. Oxidation of benzo(a)pyrene by recombinant human cytochrome P450 enzymes. Chem Res. Toxicol , 8: 136-142, 1995.
4. Kawajiri, K., Eguchi, H., Nakachi, K., Sekiya, T., and Yamamoto, M. Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer Cancer Res , 56: 72-76, 1996.
5. Bartsch, H , Castegnaro, M , Rojas, M , Camus, A-M., Alexandrov., K , and Lang, M Expression of pulmonary cytochrome P4501A1 and carcinogen DNA adduct formation in high risk subjects for tobacco-related lung cancer. Toxicol Lett. (Amst), 64/65, 477-483, 1992.
6. White, T. B , Hammond, D. K., Vásquez, H., and Strobel, H. W Expression of two cytochromes P450 involved in carcinogen activation in a human colon cell line. Mol Cell Biochem., 102: 61-69, 1991.
7. Kawajiri, K., Nakachi, K., Imai, K , Yoshii, A , Shinoda, N., and Watanabe, J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501A1 gene. FEBS Lett., 263: 131-133, 1990
8. Kawajiri, K , Nakachi, K., Imai, K., Watanabe, J., and Hayashi, S. The CYP1A1 gene and cancer susceptibility. Crit. Rev Oncol. Hematol , 14: 77-87, 1993.
9. Hamada, G. S., Sugimura, H., Suzuki, I., Nagura, K., Kiyokawa, E., Iwase, T., Tanaka, M., Takahashi, T , Watanabe, S., and Kino, I. The heme-binding region of CYP1A1, rather than the Rsa polymorphism of CYP2E1, is associated with lung cancer in Rio de Janeiro. Cancer Epidemiol., Biomarkers & Prev., 4: 63-67, 1995
10. Crofts, F., Cosma, G. N., Currie, D , Taioh, E., Toniolo, P., and Garte, S J. A novel CYP1A1 gene polymorphism in African-Americans. Carcinogenesis (Lond.), 14: 1729-1731, 1993.
11. Hayashi, S-I., Watanabe, J., Nakachi, K., and Kawajiri, K. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene. J. Biochem., 110: 407-411, 1991
12. Hayashi, S-I., Watanabe, J , Nakachi, K , and Kawajiri, K. PCR detection of an A/G polymorphism within exon 7 of the CYP1A1 gene Nucleic Acids Res , 19: 4797, 1991.
13. Hirvonen, A., Husgafvel-Pursiainen, K , Karjalainen, A., Antilla, S., and Vainio, H. Point-mutational MspI and IIe-Val polymorphisms closely linked in the CYP1A1 gene lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol., Biomarkers & Prev., 1: 485-489, 1992
14. Drakoulis, N., Cascorbi, I., Brockmöller, J., Gross, C. R., and Roots, I. Polymorphisms in the human CYP1A1 gene as susceptibility factors for lung cancer: exon-7 mutation (4889 A to G), and a T to C mutation in the 3′-flanking region. Clin. Invest , 72: 240-248, 1994.
15. Hayashi, S , Watanabe, J., and Kawajiri, K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P4501A1 and μ-class glutathione S-transferase genes. Jpn. J. Cancer Res., 83: 866-870, 1992.
16. Nakachi, K., Imai, K., Hayashi, S., and Kawajiri, K. Polymorphisms of the CYP1A1 and GST genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res., 53: 2994-2999, 1993.
17. Kihara, M., Kihara, M., and Noda, K. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis (Lond), 16: 2331-2336, 1995.
18. Hayashi, S-I., Watanabe, J., and Kawajiri, K. Expression of two types of CYP1A cDNAs in yeast cells. Proceedings of the Japanese Biochemical Society 64th Annual Meeting, Tokyo, p. 997, 1991.
19. Cosma, G , Crofts, F., Taioli, E., Toniolo, P., and Garte, S. Relationship between genotype and function of the human CYP1A1 gene. J Toxicol Environ. Health, 40: 309-316, 1993.
20. Zhang, Z , Fasco, M J., Huang, Z., Guengerich, F P , and Kaminsky, L S. Human cytochromes P4501A1 and P4501A2: R-Warfarin metabolism as a probe. Drug Metab. Disp., 23, 1339-1345, 1995.
21. Guo, Z , Gilliam, E M. J , Ohmori, S., Tukey, R. H., and Guengerich, F. P. Expression of modified human cytochrome P4501A1 in Escherichia coli effects of 5′ substitution, stabilization, purification, spectral characterization, and catalytic properties Arch. Biochem. Biophys., 312: 436-446, 1994
22. Ho., S. N , Hunt, H. D., Horton, R M , Pullen, J K., and Pease, L. R. Site-directed mutagenesis by overlap extension using the polymerase chain reaction Gene (Amst.), 77: 51-59, 1989.
23. Bauer, S , and Shiloach, J. Maximal exponential growth rate and yield of E. coli obtainable in a bench-scale fermentor. Biotechnol. Bioeng, 16: 933-941, 1974.
24. Sandhu, P., Guo, Z., Baba, T., Martin, M. V., Tukey, R. H., and Guengerich, F. P. Expression of modified human cytochrome P450 1A2 in Escherichia coli: stabilization, purification, spectral characterization, and catalytic activities of the enzyme. Arch. Biochem. Biophys., 309: 168-177, 1994
25. Kaminsky, L S , Fasco, M. J., and Guengerich, F. P. Production and application of antibodies to rat liver cytochrome P-450. Methods Enzymol. 74: 262-272, 1981
26. Thompson, C L., McCoy, Z., Lambert, J M , Andries, M. J., and Lucier, G. W. Relationships among benzo(a)pyrene metabolism, benzo(a)pyrene-diol-epoxide, DNA adduct formation, and sister chromatid exchanges in human lymphocytes from smokers and nonsmokers. Cancer Res , 49: 6503-6511, 1989
27. Ardies, C. M., Lasker, J. M., Bloswick, B. P., and Lieber, C. S. Purification of NADPH: cytochrome c (cytochrome P-450) reductase from hamster liver microsomes by detergent extraction and affinity chromatography. Anal. Biochem , 162: 39-46, 1987
28. Guengerich, F. P., Wang, P., Mitchell, M. B., and Mason, P. S Rat and human liver microsomal epoxide hydratase. Purification and evidence for the existence of multiple forms. J. Biol. Chem , 254: 12248-12254, 1979.
29. McKinney, M. M., and Parkinson, A. A simple, non-chromatographic procedure to purify immunoglobulins from serum and ascites fluid. J Immunol. Methods, 96: 271-278, 1987
30. Gonzalez, F. J., and Korzekwa, K. R. Cytochrome P450 expression systems. Annu. Rev Pharmacol Toxicol., 35: 369-390, 1995.
31. +-chelate affinity purification, and characterization of solubility and aggregation. Arch. Biochem. Biophys., 321: 277-288, 1995.
32. Gilliam, E M. J., Baba, T , Kim, B-R., Ohmori, S., and Guengerich, F. P. Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. Arch Biochem Biophys., 305: 123-131, 1993.
33. Lehnerer, M., Schulze, J., Petzold, A., Bernhardt, R , and Hlavica, P. Rabbit liver cytochrome P-450 2B5, high-level expression of the full-length protein in Escherichia coli, purification, and catalytic activity. Biochim Biophys. Acta, 1245 107-115, 1995
34. 1-P450 complementary DNA and ammo acid sequence Science (Washington DC), 228: 80-83, 1985
35. Woody, R. W. Circular dichroism. Methods Enzymol , 246 34-71, 1995.
36. Sreerama, N., and Woody, R. W A self-consistent method for the analysis of protein secondary structure from circular dichroism. Anal. Biochem., 209: 32-44, 1993.
37. Cupp-Vickery, J. R , and Poulos, T L. Structure of cytochrome P450eryF involved in erythromycin biosynthesis. Struct. Biol., 2: 144-153, 1995.
38. Lewis, D. F. Three-dimensional models of human and other mammalian microsomal P450s constructed from an alignment with P450102 (P450bm3). Xenobiotica, 25: 333-366, 1995.
39. Wedlund, P. J., Kimura, S , Gonzalez, F. J , and Nebert, D W. 1462V mutation in the human CYP1A1 gene: lack of correlation with either the Msp I 1.9 kb (M2) allele or CYP1A1 inducibility in a three-generation family of east Mediterranean descent Pharmacogenetics, 4: 21-26, 1994.
40. Petersen, D. D , McKinney, C. E , Ikeya, K., Smith, H. H., Bale, A. E , McBride, O. W , and Nebert, D W. Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. Am J. Hum. Genet., 48: 720-725, 1991.
41. Landi, M T., Bertazzi, P. A., Shields, P. G., Clark, G., Lucier, G. W., Garte, S. J., Cosma, G , and Caporaso, N. E. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics, 4: 242-246, 1994.